Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Human Polyclonal PAK1 Primary Antibody for IHC - ABIN966797
Alexander, Yang, Hinds: Cellular senescence requires CDK5 repression of Rac1 activity. in Molecular and cellular biology 2004
Show all 3 Pubmed References
Human PAK1 Primary Antibody for IHC - ABIN966796
Thiel, Reeder, Pfaff, Coleman, Sells, Chernoff: Cell cycle-regulated phosphorylation of p21-activated kinase 1. in Current biology : CB 2002
Show all 3 Pubmed References
Human Polyclonal PAK1 Primary Antibody for WB - ABIN1944750
Brown, Stowers, Baer, Trejo, Coughlin, Chant: Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway. in Current biology : CB 1997
Show all 3 Pubmed References
Human Polyclonal PAK1 Primary Antibody for ELISA, WB - ABIN188561
Zhao, Ma, Calon, Harris-White, Yang, Lim, Morihara, Ubeda, Ambegaokar, Hansen, Weisbart, Teter, Frautschy, Cole: Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. in Nature neuroscience 2006
Human Monoclonal PAK1 Primary Antibody for IF, IHC (p) - ABIN562102
Cook, Sanchez-Carbente, Lachance, Radzioch, Tremblay, Khandjian, DesGroseillers, Murai: Fragile X related protein 1 clusters with ribosomes and messenger RNAs at a subset of dendritic spines in the mouse hippocampus. in PLoS ONE 2011
Human Polyclonal PAK1 Primary Antibody for IF, IHC - ABIN362773
Rashid, Banerjee, Nikolic: Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology. in The Journal of biological chemistry 2001
Show all 4 Pubmed References
Human Polyclonal PAK1 Primary Antibody for DB, IF - ABIN389799
El-Baba, Mahadevan, Fahlbusch, S, Rau, Gali-Muhtasib, Schneider-Stock: Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer. in Molecular cancer 2014
Human Polyclonal PAK1 Primary Antibody for ICC, IF - ABIN4343458
Geiger, Velic, Macek, Lundberg, Kampf, Nagaraj, Uhlen, Cox, Mann: Initial quantitative proteomic map of 28 mouse tissues using the SILAC mouse. in Molecular & cellular proteomics : MCP 2013
results represent the first evidence that Pak1 links extracellular signals to the genetic cascade of transcription factors necessary for cranial neural crest specification
These findings expand the role of phosphoinositides in kinase signaling and suggest how altered phosphoinositide metabolism may upregulate Pak1 activity in cancer cells.
The data suggest that EphA4 activation sequesters active Cdc42 (show CDC42 Antibodies) and in this way down-regulates cell-cell adhesion.
Pak1 inhibition interferes with the guidance of mesendoderm migration by directional cues residing in the extracellular matrix of the blastocoel roof, and with mesendoderm translocation in the embryo.
PAK1 expression, evaluated by immunohistochemistry, was positively correlated with pERK (show EIF2AK3 Antibodies) and beta-catenin (show CTNNB1 Antibodies) expression in lung tumors. Patients with high-PAK1, high-pERK (show EIF2AK3 Antibodies), and high-nuclear beta-catenin (show CTNNB1 Antibodies) tumors more frequently showed an unfavorable response to cisplatin-based chemotherapy when compared to their counterparts.
PKC-zeta (show PRKCZ Antibodies) may be responsible for the abnormal growth, proliferation, and migration of metastatic LOVO colon cancer cells via PKC-zeta (show PRKCZ Antibodies)/Rac1/Pak1/beta-Catenin (show CTNNB1 Antibodies) pathway.
High expression of PAK1 is associated with invasion of gastric cancer.
Molecular modelling studies of PAK1 with its major interacting partners RHOA (show RHOA Antibodies) and STAT3 (show STAT3 Antibodies) revealed potential network gene elements in breast invasive carcinoma.
miR4855p reverses EMT (show ITK Antibodies) and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma. This study suggests that PAK1 plays an essential role in the progression of OSCC and it is a potential therapeutic target for OSCC.
Because reduced PAK1 activity impaired FA/BRCA function, inhibition of this kinase in PAK1 amplified and/or overexpressing breast cancer cells represents a plausible strategy for expanding the utility of PARP (show COL11A2 Antibodies) inhibitors to FA/BRCA-proficient cancers.
Overall, the authors find that p27 (show PAK2 Antibodies) directly promotes cell invasion by facilitating invadopodia turnover via the Rac1/PAK1/Cortactin (show CTTN Antibodies) pathway.
Results show that Pak1 is overexpressed in breast cancer cells and tissues, and found that Pak1 is a hormone responsive gene, whose expression can be modulated by steroid hormones, estrogen (E2) and progesterone (P4). Pak1 promoter analysis showed that PR mediates promoter activity via its binding to PRE present on the Pak1 promoter.
PAK1 confers TKI resistance in EGFR (show EGFR Antibodies)-mutant cells as well as in EGFR (show EGFR Antibodies)-wild-type cells.
Our findings offer an insight for the new drug development of PAK1 inhibitor. We also provide a possible explanation for the phenomenon that the application of the chlorhexidine in peritoneal lavage inhibited the development of tumor.
Depletion of active PAK1 up-regulates the immune system of APC (show APC Antibodies)(14/+) mice and suppresses intestinal tumour development. These observations suggest an important role for PAK1 in the immune response to tumours.
Because reduced PAK1 activity impaired FA/BRCA function, inhibition of this kinase in PAK1 amplified and/or overexpressing breast cancer cells represents a plausible strategy for expanding the utility of PARP (show PARP1 Antibodies) inhibitors to FA/BRCA-proficient cancers.
Results from our analysis showed that Pak1 overexpression, knockdown and Pak1 knockout cell line models showed that Pak1 confers protection to keratinocytes from UV-B-induced apoptosis and DNA damage via ATR
These results establish a novel signaling process whereby PAK1 upregulates COX-2 (show COX2 Antibodies), reduces anandamide levels and restricts tonic endocannabinoids-mediated processes.
The findings suggest that PAK1 deficiency may underlie an increased diabetic susceptibility. Discovery of ways to remediate glycaemic dysregulation via altering PAK1 or its downstream effectors offers promising opportunities for disease intervention.
present work presents the correlation between DSCAM gene overexpression and a dysregulation of the PAK pathway, resulting in altered morphological parameters of neuronal plasticity in the trisomic cell line, namely decreased number and length of processes
These results identify Pak1 and Pak2 (show PAK2 Antibodies) as redundant regulators of myoblast differentiation in vitro and in vivo and as components of the promyogenic Ncad (show CDH2 Antibodies)/Cdo (show CDO1 Antibodies)/Cdc42 (show CDC42 Antibodies) signaling pathway.
PAK-mediated phosphorylation of PKD1 at Ser203 triggers its membrane dissociation and subsequent entry into the nucleus, thereby regulating the phosphorylation of PKD1 nuclear targets, including class IIa histone deacetylases.
These results implicate PAK1 as a regulator of Pancreatic stellate cells activation, proliferation and apoptosis. Targeting stromal PAK1 could increase therapeutic response and survival of patients with pancreatic cancer.
The authors conclude that PAK1, besides its role in virus entry, also plays a relevant role in vaccinia virus dissemination.
FOXO-Pak1 pathway was recently shown to regulate mammalian neuronal polarity, our findings indicate that the roles of FOXO and Pak1 in neuronal migration are most likely conserved from C. elegans to higher organisms.
PAK1 promotes reproduction, whereas it inactivates HSP16.2 gene and shortens lifespan.
Pak-1 interacts with Wnt (show WNT2 Antibodies) signaling to regulate tissue polarity and gene expression.
only PAK-1 functions in the GIT/PIX (show ARHGEF7 Antibodies)/PAK pathway independently of RAC (show AKT1 Antibodies)/CDC42 (show CDC42 Antibodies) GTPases.
Data show that combined loss of ROCK and PAK, or ROCK and MRCK (show CDC42BPA Antibodies), completely prevented embryonic elongation, but a constitutively active form of MLC-4 could only rescue a lack of MRCK (show CDC42BPA Antibodies).
This gene encodes a family member of serine/threonine p21-activating kinases, known as PAK proteins. These proteins are critical effectors that link RhoGTPases to cytoskeleton reorganization and nuclear signaling, and they serve as targets for the small GTP binding proteins Cdc42 and Rac. This specific family member regulates cell motility and morphology. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
p21 GTPase-associated kinase 1
, p21-activated kinase 1
, p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast)
, putative CDKN1A-activated kinase 1
, STE20 homolog, yeast
, p21/Cdc42/Rac1-activated kinase 1 (yeast Ste20-related)
, serine/threonine-protein kinase PAK 1
, CDC42/RAC effector kinase PAK-A
, activated protein kinase alpha
, p21 (CDKN1A)-activated kinase 1
, protein kinase MUK2